Skip to content

The Effects of ESP Block and Mid-Transverse Process to Pleura Block on Postoperative Opioid Consumption and Quality of Recovery

Comparison of the Effects of Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) on Postoperative Opioid Consumption and Quality of Recovery in Lumbar Spinal Surgery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06815146
Enrollment
126
Registered
2025-02-07
Start date
2025-02-15
Completion date
2026-02-15
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Consumption, Quality of Recovery(QoR-40), Preoperative and Postoperative

Keywords

opioid consumption, quality of recovery

Brief summary

Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) have recently been described for the treatment of pain after lumbar spinal surgery. Although these blocks have been shown to be effective in the treatment of pain after lumbar spinal surgery when compared with postoperative pain, they have not been compared in terms of the quality of recovery and opioid consumption after lumbar spinal surgery. The aim of this clinical trial is to compare the effects of Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) on quality of recovery and opioid consumption in patients scheduled for lumbar spinal surgery. The effects of the 2 blocks on postoperative pain will also be compared and recorded.

Interventions

NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

DIAGNOSTIC_TESTQuality of Results (QoR-40)

Several rating scales have been developed to measure quality of recovery after surgery and anaesthesia, but the most extensively used is the QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain.

OTHEROpioid consuption

Opioid consuption will be recorded from PCA

Sponsors

Aydin Adnan Menderes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Masking description

Blind patients and postoperative follow-ups will not know which group the patient is in the study. Randomization will be done with computer support.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Elective Lumbar Spinal surgery performed * ASA I-III * 18-75 years old

Exclusion criteria

1. Refusal at enrollment 2. Request for withdrawal from the study 3. Inability to give informed consent 4. Emergency surgery 5. Bleeding diathesis 6. Presence of contraindications to the LA agents used in this study 7. Use of chronic opioids 8. Psychiatric disorders 9. Presence of infection at the injection site

Design outcomes

Primary

MeasureTime frameDescription
postoperative opioid consumptionPCA results will be recorded at the 1st, 6th, 12th, 24th hours postoperatively.The patient will be administered tramadol PCA every eight hours and recorded.

Secondary

MeasureTime frameDescription
quality of recovery24 hoursThe quality of recovery (QoR-40) of patients who underwent both ESP block and MTP block at the 24th hour postoperatively will be evaluated with a scoring system.

Contacts

Primary ContactSinem Sarı, Prof Dr
sarisinem@yahoo.com90 256 220 2108

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026